Medy-Tox Inc. Q3 operating profit KRW 15.5 billion, up 74.5% from a year earlier
MAI summary · Not investment advice
Medytox sold KRW 59.3 billion in Q3 and made KRW 15.5 billion from its main business, up 74.5% from a year earlier and up 226.0% from the prior quarter.
Operating profit · 3 months
KRW 15.5 billion
Key facts
- Revenue (3 months)
- KRW 59.3 billion
- Net income (3 months)
- KRW 11.6 billion
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 61.0 billion
- Revenue (year to date)
- KRW 188.7 billion
- Operating profit (prior-year 3 months)
- KRW 8.9 billion
- Operating profit (year to date)
- KRW 27.7 billion
- Net income (prior-year 3 months)
- KRW 7.2 billion
- Net income (year to date)
- KRW 22.6 billion
Commentary
AI commentary · Not investment advice
What happened
Medytox filed its consolidated quarterly report for the third quarter of 2026. Sales for the latest 3 months were KRW 593.2 billion. That is 2.8% lower than the same 3 months a year earlier (KRW 610.2 billion). It is also 13.7% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the latest 3 months was KRW 155.3 billion. That is 74.5% higher than a year earlier (KRW 88.99 billion). It is 226.0% higher than the previous quarter.
What changes for shareholders
Net income (the final profit after taxes and other costs) for the latest 3 months was KRW 116.2 billion. That is 61.4% higher than a year earlier (KRW 71.99 billion). It is 271.4% higher than the previous quarter.
For the year to date, from January 1 to September 30, sales were KRW 1,887.1 billion. Operating profit was KRW 276.7 billion. Net income was KRW 226.2 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist